Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Hodgkin Disease 50Lymphoma 45Testicular Neoplasms 13Teratoma 12HIV Infections 12Acquired Immunodeficiency Syndrome 11Lymphoma, Large B-Cell, Diffuse 10Lymphoma, Non-Hodgkin 9Head and Neck Neoplasms 8Endodermal Sinus Tumor 8Testicular Germ Cell Tumor 7Sarcoma, Kaposi 7Neoplasms 7Carcinoma, Embryonal 7Seminoma 6Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, Follicular 6Ovarian Neoplasms 5Ovarian Germ Cell Cancer 5Recurrence 4Neoplasms, Germ Cell and Embryonal 4Neoplasm Metastasis 4Carcinoma, Squamous Cell 4Vulvar Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Breast Neoplasms 3Teratoma, Testicular 2Skin Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Drug-Related Side Effects and Adverse Reactions 2

Interventions

Cyclophosphamide 45Prednisone 31N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 29Vincristine 28Doxorubicin 27Etoposide 22romidepsin 20Gemcitabine 18Lenalidomide 1610-propargyl-10-deazaaminopterin 16fludarabine phosphate 15Whole-Body Irradiation 15Peripheral Blood Stem Cell Transplantation 14Brentuximab Vedotin 14Azacitidine 13Mycophenolic Acid 12Dexamethasone 10Cyclosporine 10Bortezomib 10Alemtuzumab 10Rituximab 8fludarabine 7belinostat 7Methotrexate 6Cytarabine 6Busulfan 6Bendamustine Hydrochloride 6pembrolizumab 5denileukin diftitox 5Nivolumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, T-Cell, Peripheral × Bleomycin × Clear all
NCT00136565 2018-08-23

Study of Bortezomib Combined With ACVBP in Peripheral T-cell Lymphoma

Lymphoma Study Association

Phase 2 Completed
60 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡